-
May 12, 2008
Non-invasive Test Effective for Colorectal Cancer Screening
A new, non-invasive colorectal cancer screening test from Exact Science is now available and supported by the American Cancer Society and other major medical groups. Study results showing the test’s efficacy have been reported in the April 2008 supplement of Gastroenterology.
-
May 12, 2008
Mammography Can Measure Growth Rate of Breast Cancer Tumor
New research indicates that screening mammography may provide estimates of breast cancer tumor growth rates. These findings from the Norwegian Breast Cancer Screening Program were recently published in Breast Cancer Research.
-
May 12, 2008
Fludara® Not Superior to Chlorambucil for Elderly with CLL
According to results presented at the 2007 annual meeting of the American Society of Hematology, the chemotherapy agent Fludara® (fludarabine) does not appear superior to chlorambucil in elderly patients with chronic lymphocytic leukemia.
-
May 9, 2008
Stem Cell Transplant Procedures Vary Throughout the World
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas). These findings were published in the Journal of Clinical Oncology.
-
May 9, 2008
Genetic Variation Associated with Risk of Neuroblastoma
Individuals with a common genetic variation (change in DNA) on the chromosome band 6p22 have a significantly increased risk of developing neuroblastoma, as well as an increased risk for disease relapse and advanced disease. These results were recently published in an early online article in the New England Journal of Medicine.
-
May 9, 2008
Prostate cancer deaths fall after screening program
NEW YORK (Reuters Health) - Prostate cancer deaths fell substantially in the decade after one Austrian state began free PSA screening tests for all men ages 45 to 75, according to a new study.
-
May 9, 2008
Colon Cancer Outcomes Differ Between Men and Women
Variations within the gene responsible for epidermal growth factor receptors (EGFR) may be predictive of differing outcomes between male and female patients diagnosed with metastatic colon cancer. Details of the study have recently been published in the Journal of Cancer Research.
-
May 9, 2008
Being breast-fed may lower breast cancer risk
NEW YORK (Reuters Health) - Adult women who were breast-fed as infants may have a lower risk of developing breast cancer than those who were not breast-fed, unless they were first-born, study findings suggest.
-
May 9, 2008
New health woes as China moves from famine to feast
BEIJING (Reuters) - Evening exercise classes at the Nirvana fitness centre in Beijing are in high demand these days as young professionals whose mothers once counted ration cards seek to stay svelte despite lavish lunches.
-
May 8, 2008
PET Scans Often Impact Physicians’ Treatment Decisions
A recently published study finds that results from positron emission tomography (PET) scans often influence a physician’s intended management plan among elderly patients diagnosed with cancer. Full details of the study were published in the Journal of Clinical Oncology.
-
May 8, 2008
Top US lawmaker reprimands drugmakers over ads
WASHINGTON (Reuters) - Pharmaceutical companies need to be more responsible in touting their products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on Thursday.
-
May 8, 2008
Nexavar® Shows Promise for the Treatment of Advanced Melanoma
Researchers from the United States have recently reported that, among patients with advanced melanoma, the addition to chemotherapy of the drug Nexavar® (sorafenib) improved progression-free survival. Full details of the study were published in the Journal of Clinical Oncology.
-
May 8, 2008
Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma
Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease and have a worse prognosis than those with smaller masses. These findings were published in Lancet Oncology.
-
May 8, 2008
Researchers find neuroblastoma genes
BOSTON (Reuters) - An international team of researchers said they have pinpointed three variants of the genetic code that appear to set the stage for aggressive neuroblastoma, the deadliest solid tumor in early childhood.
-
May 8, 2008
Firefighters show higher risks of certain cancers
NEW YORK (Reuters Health) - A new study suggests that firefighters face higher-than-average risks of several types of cancer, adding to evidence that the job carries hazards beyond the fires themselves.
-
May 8, 2008
Five percent of breast tumors may double in month
LONDON (Reuters) - Five percent of breast cancer tumors appear to double in size in just over a month, Norwegian researchers said on Thursday in a study underscoring the potential benefits of more frequent screening.
-
May 7, 2008
Updates in the Management of Prostate and Kidney Cancers
A report from the 2008 ASCO Genitourinary Cancers Symposium
-
May 7, 2008
Physicians with More Training Perform More Effective Colonoscopies
A recent trial conducted at 15 different medical centers in Korea indicates that a physician must perform at least 150 colonoscopies to be considered competent at the procedure. Details of the study were recently published in the journal Gastrointestinal Endoscopy.
-
May 7, 2008
Changes in Lifestyle May Improve Quality of Life for Colon Cancer Survivors
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among colon cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
-
May 7, 2008
REFILE: FDA concerned over wider use of opioid analgesic
WASHINGTON (Reuters) - Approving Cephalon Inc's pain drug Fentora for patients without cancer could have "devastating effects," a U.S. Food and Drug Administration official said in documents released on Friday.
-
May 7, 2008
Phone counseling helpful after cervical cancer
NEW YORK (Reuters Health) - Telephone counseling may give cervical cancer survivors a boost to their well-being, and possibly their immune function as well, a small study suggests.
-
May 7, 2008
Euthanasia still a dilemma for Dutch doctors
AMSTERDAM (Reuters) - "I am not a monster. I'm also not a God. In the best case I'm an angel," muses a doctor in a Dutch play about euthanasia, before delivering a lethal injection to an old friend, a cancer patient.
-
May 7, 2008
IUDs seen to reduce cancer risk
WASHINGTON (Reuters) - Intrauterine devices are not only among the most effective contraceptives, but they also can help protect women from a cancer of the uterus called endometrial cancer, researchers reported on Tuesday.
-
May 6, 2008
Costs of Cancer to Medicare Evaluated
The five-year net cost to Medicare for patients diagnosed with cancer in 2004 is over 21 billion dollars. These results were recently reported in the Journal of the National Cancer Institute.
-
May 6, 2008
New Treatment Combination for Bile Duct Cancer May Improve Survival
A recent study indicates that the combination of photodynamic therapy (PDT) and endoscopic retrograde cholangiopancreatiography (ERCP) may improve survival for patients with bile duct cancer. These findings were published in Clinical Gastroenterology and Hepatology.
-
May 6, 2008
Specific Gene Mutations May Affect Response to Tamoxifen in Breast Cancer
Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute.
-
May 6, 2008
Some smoking-related risks cut soon after quitting
NEW YORK (Reuters Health) - Deaths from vascular disease due to smoking are substantially reduced in women within 5 years after they quit smoking, according to findings from the Nurses' Health Study.
-
May 6, 2008
Acid blockers don't affect colon cancer risk
NEW YORK (Reuters Health) - Taking drugs that block the secretion of gastric acid does not appear to increase the risk of developing colorectal cancer, according to a new report.
-
May 5, 2008
Specific Gene Expression Predicts Risk for Prostate Cancer
Expression of the PTOV1 gene helps predict the likelihood of the development of prostate cancer among men with high-grade prostatic intraepithelial neoplasia (HG-PIN). These results were recently published in the journal Clinical Cancer Research.
-
May 5, 2008
Treanda® Included in NCCN Guidelines for CLL and NHL
The chemotherapy agent Treanda® (bendamustine) has been added to the treatment guidelines of the National Comprehensive Cancer Network (NCCN) as an accepted treatment option for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL).
-
May 5, 2008
Wal-Mart expanding its low-priced drug program
NEW YORK (Reuters) - Wal-Mart Stores Inc expanded its low-priced drug program, saying on Monday that it is now offering more than 1,000 over-the-counter items for $4 or less and selling some 90-day generic prescriptions for $10.
-
May 5, 2008
Experimental sedative seems to work: US FDA staff
WASHINGTON (Reuters) - An experimental sedative from Japan's Eisai Co Ltd appears effective based on a preliminary evaluation of data, U.S. drug reviewers said in an analysis released on Monday.
-
May 5, 2008
Changes in Lifestyle May Improve Quality of Life for Prostate Cancer Survivors
A recent study conducted by the American Cancer Society reports that although few cancer survivors follow recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among prostate cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
-
May 2, 2008
Changes in Lifestlye May Improve Quality of Life for Breast Cancer Survivors
A recent study conducted by the American Cancer Society reports that although few cancer survivors are following recommendations for lifestyle changes aimed to improve health and well-being, adhering to these guidelines may improve quality of life among breast cancer survivors. Full details of the study were recently published in the Journal of Clinical Oncology.
-
May 2, 2008
FDA concerned over wider use of opioid analgesic
WASHINGTON (Reuters) - Approving Cephalon Inc's pain drug Fentora for patients without cancer could have "devastating effects," a U.S. Food and Drug Administration official said in documents released on Friday.
-
May 2, 2008
Work exposure to weed killers tied to brain cancer
NEW YORK (Reuters Health) - Women whose jobs regularly expose them to weed killers may have a higher-than-normal risk of a particular form of brain cancer, results of a U.S. study suggest.
-
May 2, 2008
Wider pain drug use could cause abuse: FDA
WASHINGTON (Reuters) - Widening approval for Cephalon Inc's Fentora pain drug to patients without cancer could have "devastating effects," a U.S. Food and Drug Administration official said in documents released on Friday.
-
May 2, 2008
Renee Zellweger producing breast cancer TV movie
-
May 1, 2008
More kids fainting after shots, CDC reports
WASHINGTON (Reuters) - An unprecedented number of U.S. youngsters are fainting after getting shots, especially teenage girls, and doctors need to keep an eye on them, federal health experts cautioned on Thursday.
-
May 1, 2008
Congress votes to ban genetic discrimination
WASHINGTON (Reuters) - A landmark bill to forbid discrimination against people whose genetic information shows a predisposition to certain illnesses won final U.S. congressional approval on Thursday.
-
May 1, 2008
US Congress votes to ban genetic discrimination
WASHINGTON (Reuters) - A landmark bill to forbid discrimination against people whose genetic information shows a predisposition to certain illnesses won final U.S. congressional approval on Thursday.
-
May 1, 2008
Gene effect on colon cancer differs by gender
NEW YORK (Reuters Health) - Whether variant forms of a gene called EGFR increase or decrease survival with colon cancer depends on whether the patient is male or female, new study findings indicate.
-
May 1, 2008
Genetic Differences Associated with Outcomes in Acute Myeloid Leukemia
It appears that different genetic mutations (alterations) affect outcomes among patients with acute myeloid leukemia. These results were recently published in the New England Journal of Medicine.
-
May 1, 2008
Some women not told about breast reconstruction
NEW YORK (Reuters Health) - Doctors don't universally discuss the option of breast reconstruction with all women undergoing mastectomy, results of a new study confirm.
-
May 1, 2008
Ontario moves to ban smoking in cars with children
TORONTO (Reuters) - Smokers in the Canadian province of Ontario will be fined C$250 ($247) for lighting up in their cars in the presence of children, if a new law introduced on Wednesday is passed.
-
May 1, 2008
No Benefit with Addition of Platinol® to Treatment for Anal Cancer
Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published by the Journal of the American Medical Association.
-
May 1, 2008
Changes in Lifestyle May Improve Quality of Life for Cancer Survivors
A recent study conducted by the American Cancer Society reports that few cancer survivors are following recommendations for lifestyle changes, such as regular exercise, increased fruit and vegetable consumption, and smoking cessation. Full details of the study were recently published in the Journal of Clinical Oncology.
-
April 30, 2008
Regular Aspirin Use May Reduce Risk of Hormone-positive Breast Cancer
Regular use of aspirin may modestly reduce the risk of developing hormone-positive breast cancer. These results were recently published online by Breast Cancer Research.
-
April 30, 2008
Aspirin seen cutting risk of type of breast cancer
WASHINGTON (Reuters) - A daily aspirin may give women modest protection against the most common type of breast cancer, U.S. government researchers said on Wednesday.
-
April 30, 2008
Avastin® plus Chemotherapy Shows Promise for Treatment of Non–Small Cell Lung Cancer
The combination of Avastin® (bevacizumab), Gemzar® (gemcitabine), and Platinol® (cisplatin) prolonged progression-free survival when compared with chemotherapy alone among patients with non-small cell lung cancer. These results were recently reported by the pharmaceutical company Genentech.